In recent years, researchers have turned to gene editing to address the limitations of CAR T therapies. This roundup summarises the clinical-stage...

This week's update includes news about two gene-edited therapies for cancer. Allogene Therapeutics' ALLO-316 has been granted Fast Track Designation...

In this piece, we provide selected highlights from the 63rd American Society of Hematology annual meeting, held from December 11-14th 2021.

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Verve Therapeutics demonstrates preclinical proof-of-concept with support from Beam Therapeutics

Multiple new deals and developments and new base editor data from Intellia Therapeutics